NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Omeros Corporation 

1420 Fifth Avenue, Suite 2675

Seattle  Washington  98101  U.S.A.
Phone: 206-623-4688 Fax: 206-264-7856


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 11/20/2009 10:32:53 AM    More...
Omeros Corporation, First U.S. Biotech IPO Since February 2008, Sees Shares Drop 13 Percent in First Day 10/9/2009 7:07:32 AM    More...
Omeros Corporation Raises $68.2M in Washington's First IPO in Two Years 10/8/2009 6:49:49 AM    More...
Omeros Corporation Announces IPO of 6.8 Million Shares 9/18/2009 6:44:41 AM    More...
Omeros Corporation Moves Closer To IPO, Sets Price Goal 9/17/2009 7:59:51 AM    More...
Omeros Corporation Plans to Test Waters with First Washington IPO in Two Years, Sources Say 8/27/2009 7:08:13 AM    More...
Omeros Corporation Announces Positive Clinical Results of Phase 1/Phase 2 Trial of OMS302 for Use During Ophthalmologic Surgery 8/11/2009 6:40:39 AM    More...
Omeros Corporation Appoints New Vice President of Clinical Development 8/5/2009 9:01:54 AM    More...
Omeros Corporation Receives $3.1 Million Milestone Payment from The Stanley Medical Research Institute for Schizophrenia Program 1/28/2009 11:17:24 AM    More...
Omeros Corporation Awarded Grant from The Michael J. Fox Foundation to Evaluate Novel Parkinson's Disease Target 1/7/2009 8:37:51 AM    More...
123